CAS: 5467-78-7 - Fenamole
Formula:C7H7N5
InChI:InChI=1S/C7H7N5/c8-7-9-10-11-12(7)6-4-2-1-3-5-6/h1-5H,(H2,8,9,11)
InChI key:InChIKey=ULIDRMKBVYYVIQ-UHFFFAOYSA-N
SMILES:N=1N=C(N)N(N1)C=2C=CC=CC2
- Synonyms:
- 1-Phenyl-1H-1,2,3,4-tetrazol-5-amine
- 1-Phenyl-1H-tetrazol-5-ylamine
- 1-Phenyl-5-aminotetrazole
- 1-Phenyltetrazol-5-amine
- 1-phenyl-1H-tetrazol-5-amine
- 1H-Tetrazol-5-amine, 1-phenyl-
- 1H-Tetrazole, 5-amino-1-phenyl-
- 5-Amino-1-phenyl-1H-tetrazole
- 5-Amino-1-phenyltetrazole
- Al 0559
- See more synonyms
- Fenamol
- Fenamol [INN-Spanish]
- Fenamole [USAN:INN]
- Fenamolum
- Fenamolum [INN-Latin]
- Nsc 25413
- P 463
- Unii-K4H264Pbq7
- Fenamole
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Fenamole REF: TM-T31764CAS: 5467-78-7 | - - - | 1,428.00 € | Fri 03 Jan 25 | |
1-Phenyl-1H-1,2,3,4-tetrazol-5-amine REF: 3D-FAA46778CAS: 5467-78-7 | Min. 95% | To inquire | Thu 13 Feb 25 | |
1-phenyl-1H-tetrazol-5-amine REF: 10-F311391CAS: 5467-78-7 | 95.0% | - - - | Discontinued product |
Fenamole
CAS:5467-78-7
Fenamole is a biochemical.
Formula:
C7H7N5
Color and Shape:
Solid
Molecular weight:
161.164
Ref: TM-T31764
25mg | 1,428.00 € |
Estimated delivery in United States, on Friday 3 Jan 2025
1-Phenyl-1H-1,2,3,4-tetrazol-5-amine
CAS:5467-78-7
The compound 1-Phenyl-1H-1,2,3,4-tetrazol-5-amine is a growth factor that is used in pharmaceutical preparations. The reactive …
Formula:
C7H7N5
Purity:
Min. 95%
Molecular weight:
161.16 g/mol
Ref: 3D-FAA46778
1g | 1,021.00 € | ||
100mg | 271.00 € |
Estimated delivery in United States, on Thursday 13 Feb 2025
1-phenyl-1H-tetrazol-5-amine
CAS:5467-78-7
Purity:
95.0%
Color and Shape:
Solid, Light beige powder
Molecular weight:
161.16799926757812
Ref: 10-F311391
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |